Wellcome

Nanobiomaterials in drug delivery : (Record no. 503921)

MARC details
000 -LEADER
fixed length control field 04915cam a2200541Ii 4500
001 -
control field ocn948296971
003 -
control field OCoLC
005 -
control field 20190719103232.0
006 -
fixed length control field m o d
007 -
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160429s2016 enk ob 001 0 eng d
040 ## -
-- N$T
-- eng
-- rda
-- pn
-- N$T
-- OPELS
-- N$T
-- YDXCP
-- OCLCF
-- YDX
-- UPM
-- U3W
-- D6H
-- AU@
-- WYU
019 ## -
-- 958084149
-- 958392409
-- 1066462332
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323428668
Qualifying information electronic bk.
International Standard Book Number 0323428665
Qualifying information electronic bk.
-- 9780323428668
Qualifying information print
International Standard Book Number 9780323428897
International Standard Book Number 0323428894
035 ## -
-- (OCoLC)948296971
-- (OCoLC)958084149
-- (OCoLC)958392409
-- (OCoLC)1066462332
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
-- TA418.9.N35
072 #7 -
-- TEC
-- 009000
-- bisacsh
-- TEC
-- 035000
-- bisacsh
082 04 -
Classification number 620.1/15
-- 23
245 00 - TITLE STATEMENT
Title Nanobiomaterials in drug delivery :
Remainder of title applications of nanobiomaterials /
Statement of responsibility, etc edited by Alexandru Mihai Grumezescu.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
505 0# -
Formatted contents note Front Cover; Nanobiomaterials in Drug Delivery; Copyright Page; Contents; List of contributors; Preface of the series; Preface; About the Series (Volumes I-XI); About Volume IX; 1 Nanobiomaterials in drug delivery; Abbreviations; 1.1 Introduction; 1.1.1 Parameters of Delivery of Nanoparticles into Biological Systems; 1.1.2 Intratumor Drug Release; 1.1.3 Biological Clearance; 1.1.4 Toxicity of Nanoparticles; 1.2 Preparation and Characterization of Nanomaterials; 1.2.1 Preparation; 1.2.2 Characterization; 1.2.2.1 Physicochemical characterization.
Formatted contents note 1.3 Nanotechnology-Assisted Formulating of Poorly Water-Soluble Compounds1.4 Biodegradable Polymers Used in Controlled Drug Delivery; 1.5 Multifunctional Nanomaterials for Cancer Therapy; 1.5.1 Targeting; 1.5.2 Imaging; 1.5.3 Chemotherapy; 1.6 Chemical Conjugation of Nanomaterials; 1.6.1 pH-Sensitive Linkages Used for Bioconjugation of Nanomaterials; 1.6.2 Other Chemical Linkages Used for Bioconjugation of Nanomaterials; 1.7 Conclusions; Acknowledgments; References; 2 Dendrimers in drug delivery; 2.1 Introduction; 2.2 Mechanisms of Interaction Between Dendrimers and Drug Molecules.
Formatted contents note 2.3 Dendrimers as Carriers of Various Types of Drugs2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); 2.3.2 Anticancer Drugs; 2.3.3 Other Drugs; 2.4 Routes of Administration of Drug-Dendrimers Complexes; 2.4.1 Dendrimers in Intravenous Drug Delivery; 2.4.2 Dendrimers in Oral Drug Delivery; 2.4.3 Dendrimers in Transdermal Drug Delivery; 2.4.4 Dendrimers in Ocular Drug Delivery; 2.4.5 Dendrimers in Pulmonary Drug Delivery; 2.5 Conclusions and Further Prognosis; Acknowledgments; References; 3 Lipid nanoparticles as non-viral vectors for siRNA delivery: concepts and applications.
Formatted contents note 3.1 Introduction3.2 siRNA: Definition, Mechanism, and Applications; 3.3 Hurdles for siRNA Delivery; 3.4 Strategies to Overcome the Hurdles of siRNA Delivery; 3.4.1 Chemical Modifications in siRNA; 3.4.2 Physical Methods for siRNA Delivery; 3.4.3 Viral Carriers for siRNA Delivery; 3.4.4 Non-viral Carriers for siRNA Delivery; 3.5 Liposomes: The Influence of Charge and Lipid Composition for siRNA Delivery; 3.5.1 Cationic Lipid-Based siRNA Delivery Systems; 3.5.2 Neutral Lipid-Based siRNA Delivery Systems; 3.5.3 Anionic Lipid-Based siRNA Delivery Systems; 3.5.4 Stealth Liposomes.
Formatted contents note 3.6 Targeted Delivery of siRNA-Loaded Liposomes3.7 Combined Therapy of siRNA-Loaded Liposomes and Conventional Small-Molecule Drugs; 3.8 siRNA-Loaded Liposomes Associated with Physical Methods; 3.9 siRNA-Loaded Liposomes: Clinical Studies; 3.10 Conclusions and Perspectives; References; 4 Nanobiomaterials: Novel nanoplatforms for protein and peptide delivery; 4.1 Introduction; 4.2 Proteins/Peptides as Therapeutics; 4.2.1 Group I-Protein Therapeutics with Enzymatic or Regulatory Activity; 4.2.2 Group II-Protein Therapeutics with Special Targeting Activity; 4.2.3 Group III-Proteinaceous Vaccines.
650 #0 -
Topical term or geographic name as entry element Nanostructured materials.
Topical term or geographic name as entry element Nanomedicine.
Topical term or geographic name as entry element Nanobiotechnology.
Topical term or geographic name as entry element TECHNOLOGY & ENGINEERING / Engineering (General)
Topical term or geographic name as entry element TECHNOLOGY & ENGINEERING / Reference
Topical term or geographic name as entry element Nanobiotechnology.
Topical term or geographic name as entry element Nanomedicine.
Topical term or geographic name as entry element Nanostructured materials.
700 1# -
Personal name Grumezescu, Alexandru Mihai,
Relator term editor.
856 40 -
Uniform Resource Identifier http://www.sciencedirect.com/science/book/9780323428668
264 #1 -
-- Kidlington, Oxford, UK :
-- William Andrew is an imprint of Elsevier,
-- 2016.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
504 ## -
-- Includes bibliographical references and index.
588 0# -
-- Online resource; title from PDF title page (ScienceDirect, viewed May 9, 2016).
-- bisacsh
-- bisacsh
-- fast
-- (OCoLC)fst01894713
-- fast
-- (OCoLC)fst01744350
-- fast
-- (OCoLC)fst01032630
655 #4 -
-- Electronic books.
856 40 -
-- ScienceDirect
Holdings
Withdrawn status Lost status Damaged status Home library Current library Date acquired Total Checkouts Barcode Date last seen Koha item type
      Mysore University Main Library Mysore University Main Library 19/07/2019   EBKELV222 19/07/2019 Ebooks

No. of hits (from 9th Mar 12) :

Powered by Koha